Helius is a New Zealand-owned biotechnology company focused on medicinal cannabis research and development. The country’s largest licensed producer and the first medicinal cannabis cultivator to be certified as New Zealand Grown through Buy NZ Made Campaign, Helius a leader in this nascent market. The company operates a state-of-the-art GMP facility in Auckland with indoor controlled growing systems, integrated extraction site, an advanced cannabinoid research laboratory and manufacturing operations. Following changes in New Zealand’s regulatory environment, Helius is poised to set the standard for effective and accessible medicinal cannabis products.

Biotechnology

Helius Therapeutics

Paul Manning

Mary Alice Simon

Mark Woods

Gavin Pook

Nick Williams

JP Schmidt

Carmen Doran

Dr Jim Polston

Leila De Koster

Bruce Wallace

The leadership team at Helius Therapeutics has a wealth of experience in both the medical and engineering industries. Board members have sat on the New Zealand Medical Cannabis Council and have worked as Operations Managers and General Managers in a variety of companies. The team is also highly educated, with degrees in Mechanical and Biomedical Engineering from the University of Canterbury.

Leadership Team

CEO and Executive Team

Board of Directors

Leadership Team

About

Team members

Other teams at Helius Therapeutics

CEO and Executive Team

Board of Directors